| WD065KJ |
N,N-Dimethylhexylamine |
4385-04-0 |
Detail |
| WD065KK |
3-(2,3-Dimethyl-phenoxymethyl)-4-methoxy-benzaldehyde |
438530-90-6 |
Detail |
| WD065KL |
6-Bromo-2-(4-isopropylphenyl)quinoline-4-carboxylic acid |
438531-43-2 |
Detail |
| WD065KM |
Potassium (3-methoxyphenyl)trifluoroborate |
438553-44-7 |
Detail |
| WD065KN |
3,5-dimethoxy-4-hydroxyphenylacetic acid |
4385-56-2 |
Detail |
| WD065KO |
2-(4-Methoxy-benzoylamino)-4-methyl-pentanoic acid |
438581-55-6 |
Detail |
| WD065KP |
Pyrrolidine-2-carboxylic acid 3,4-dimethoxy-benzylamide |
438581-56-7 |
Detail |
| WD065KQ |
(1-methanesulfonylpiperidin-4-yl)methanamine |
438585-61-6 |
Detail |
| WD065KR |
6-Bromo-3-chloro-1-benzothiophene-2-carboxylic acid |
438613-29-7 |
Detail |
| WD065KS |
Glucagon Receptor Antagonist I |
438618-32-7 |
Detail |